|
|
Preparation and characterization of vesiculin, a two-chain protein derived from IGF-2
Mrzílková, Karolína ; Žáková, Lenka (advisor) ; Pačesová, Andrea (referee)
Hormones of insulin family are one of the most studied groups of proteins due to their connection to large number of diseases including type two diabetes mellitus, tumorigenesis and some neurodegenerative diseases. The newest member of this superfamily is a two-chain analogue of IGF-2 called vesiculin. This peptide was originally isolated from secretory granules of mouse βTC6-F7 cell line and is currently believed to have a endocrine or paracrine effect on pancreatic β-cells. Its sequence homology with IGF-2 and structural similarity to insulin foreshadows vesiculin's potential metabolic, proliferation and growth properties and further secures its place as scientifically interesting and clinically lucrative topic. The insulin theme is corelated with insulin resistance, pathological state present primarily in early stages of development of type two diabetes mellitus. Vesiculin is able to stimulate glucose uptake and glycogen synthesis even in this condition which differentiates it form insulin and IGF-2 whose glucoregulatory activity is blunted in face of insulin resistance. Further research of vesiculin and insulin family receptor interaction, including dimeric tyrosinekinase receptor for IGF-1 and insulin, but also monomeric IGF-2 receptor, can provide more knowledge on character of this binding...
|
|
|
Immune stimulation by lipid nanoparticles
Aulichová, Veronika ; Grantz Šašková, Klára (advisor) ; Pačesová, Andrea (referee)
Lipid nanoparticles are the most advanced non-viral delivery system of nucleic acids. They enable safe and efficient transport of nucleic acids to the targeted cells and represent a key enabling technology of RNA therapeutics. RNA therapeutics represent a rapidly emerging field of genetic medicine; however, due to the nature of RNA molecules and their susceptibility to nuclease degradation, the delivery system is crucial for its translation to the clinic. This thesis explores the ability of lipid nanoparticles based on the XMAN6 ionizable lipidoid to elicit an immune response against mRNA-encoded antigen. XMAN6 is a lead lipidoid from a new class of adamantane-based ionizable lipidoids developed in our team. The mRNA-LNP formulations were first tested in vitro to evaluate their functionality and cytokine production and then in vivo using a mouse model. LNPs were applied via two different routes and in different experimental set ups, and their safety was evaluated by analyzing mouse activity. The data showed that XMAN6 is a promising lipidoid for in vivo delivery of mRNA. The mRNA-LNPs successfully induced the antibody response against the encoded antigen by intraperitoneal and intramuscular application. XMAN6 LNPs showed to be suitable for in vivo use, as they were well tolerated and caused only...
|
|
| |
guest ::
RSS feed.